SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-08-012104
Filing Date
2008-02-27
Accepted
2008-02-27 17:16:16
Documents
8
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 v105021_10k.htm 10-K 2910513
2 GRAPHIC chart.jpg GRAPHIC 64178
3 v105021_ex21-1.htm EX-21.1 8791
4 v105021_ex23-1.htm EX-23.1 14878
5 v105021_ex31-1.htm EX-31.1 20261
6 v105021_ex31-2.htm EX-31.2 20413
7 v105021_ex32-1.htm EX-32.1 6825
8 v105021_ex32-2.htm EX-32.2 7505
  Complete submission text file 0001144204-08-012104.txt   3079050
Mailing Address
Business Address 750 LEXINGTON AVENUE . NEW YORK NY 10022 212-531-5965
KERYX BIOPHARMACEUTICALS INC (Filer) CIK: 0001114220 (see all company filings)

IRS No.: 134087132 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-30929 | Film No.: 08647444
SIC: 2834 Pharmaceutical Preparations